BioCentury | Sep 28, 2006
Financial News

Gamida Cell raises $16 million

...raised $16 million in a series D round led by Israel Healthcare Ventures. Existing investors Elscint...
BioCentury | Aug 9, 2004
Emerging Company Profile

Corporate Profile

...24 Funds raised: $21.8 million Investors: Teva Pharmaceutical Industries; Biomedical Investements; Denali; Auriga Ventures; Comverse; Elscint...
Items per page:
1 - 2 of 2
BioCentury | Sep 28, 2006
Financial News

Gamida Cell raises $16 million

...raised $16 million in a series D round led by Israel Healthcare Ventures. Existing investors Elscint...
BioCentury | Aug 9, 2004
Emerging Company Profile

Corporate Profile

...24 Funds raised: $21.8 million Investors: Teva Pharmaceutical Industries; Biomedical Investements; Denali; Auriga Ventures; Comverse; Elscint...
Items per page:
1 - 2 of 2